SHE:002873 Revenue

Guiyang Xintian Pharmaceutical had revenue of 193.15M CNY in the quarter ending March 31, 2025, with 8.93% growth. This brings the company's revenue in the last twelve months to 873.38M, down -5.33% year-over-year. In the year 2024, Guiyang Xintian Pharmaceutical had annual revenue of 857.55M, down -10.11%.

Revenue (ttm)

873.38M

Revenue Growth

-5.33%

P/S Ratio

2.30

Revenue / Employee

446.06K

Employees

1,958

Market Cap

2.01B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	857.55M	-96.43M	-10.11%
Dec 31, 2023	953.98M	-133.69M	-12.29%
Jan 1, 2023	1.09B	117.83M	12.15%
Jan 1, 2022	969.84M	218.90M	29.15%
Dec 31, 2020	750.95M	-22.39M	-2.90%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Jiangsu Hengrui Medicine	29.19B
Shenzhen Mindray Bio-Medical Electronics	35.59B
WuXi AppTec	39.59B
Zhangzhou Pientzehuang Pharmaceutical.,	10.76B
Aier Eye Hospital Group	21.81B
Sichuan Biokin Pharmaceutical	5.82B
Shanghai United Imaging Healthcare	10.43B
Yunnan Baiyao Group Co.,Ltd	40.10B

Revenue Rankings